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Abstract Cervical cancer can be not only prevented, but also effectively treated. Decreased 
efficiency of biochemical, neurohormonal and/or immunological mechanisms 
leads to infectious states which, irrespective of their bacterial, viral or parasitic 
aetiology, are only the necessary, but not the sufficient causes of neogenesis. The 
cause of cancer is the natural and common phenomenon of the self-organization 
of systems, endangered by ending of their existence, into more efficient time-
space structures at the expense of their surrounding. Infected cells or infectiously 
changed tissues in their final phase of existence are often recognized as a precan-
cerous state, but their genome does not differ from other organism cells, and that 
is why the carcinogenesis can still be prevented by direct fighting of pathogenic 
microorganisms, and indirectly by strengthening the body by neurohormonal 
therapy or vaccine immunopotentialization. Primary prophylaxis of neoplasms 
requires that not only the dissipathogenic state of cells be prevented, but also their 
tissue surrounding be normalized to head off the risk of the self-organization of 
neoplastic forms of life, differing in their genetic identity from the surrounding 
cells. Lactovaginal immunopotentialization complements the conservative and 
operative methods of oncological treatment, as well as has prophylactic applica-
tion in women with the history of miscarriages, premature deliveries, lack of or 
significantly shortened lactation, neurohormonal menstruating disorders, chronic 
and recurrent inflammations of the reproductive organs, long-term hormonal 
contraception and hormone replacement therapy during menopause, or only 
deficiency of Lactobacillus vaginalis, as indicators of risk of cervical cancer. 
INTRODUCTION
The medicine of the 21st century makes use of the 
newest technology developed in the previous cen-
tury thanks to the achievements of the quantum 
mechanics and thermodynamics, as well as identi-
fication of energy and mass in a simplified A. Ein-
stein’s equation: E=mc2. Unfortunately, it requires 
concurrent adaptation of the nursing, prophylaxis, 
prevention, diagnostics, treatment and reha-
bilitation principles to the same level of general 
knowledge. This, in turn, forces doctors not only 
to change their opinions, but also to reevaluate 
their professional habits, which proves even more 
difficult. From the history of medicine, we know 
the initial difficulties with practical use of break-
through discoveries of the organism cell structure, 
the presence of bacteria and viruses, X-radiation, 
computer tomography and more recently – imag-
ing and spectroscopy with the use of nuclear mag-
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netic resonance. In each of those stages of medicine 
development, discovering the mystery of cancer as the 
most tragic disease in a human being was attempted, 
each time by associating it with new causes. Although 
now aetiology is distinguished from pathogenesis, still 
too many people consider cancer as both the cause and 
the neoplastic disease itself.
The biggest achievement of the molecular biology 
of the 20th century was the discovery of the human 
genome structure, which, however, did not fulfil the 
medical expectations. It turned out that genes, made 
of deoxyribonucleic acids, only in connection with 
adequate ribonucleic acids and proteins make up the 
inheritance unit, which was first called a gene. Other-
wise, the organism cells, which have the same genome, 
could not have been differentiated. Oncogenes and 
prooncogenes suffered the same fate in the attempts 
made at explaining the etiopathogenesis of neoplasms. 
Then, in the middle of the human genome, sequences 
of nucleotides corresponding to known viruses were 
found. Finally, alongside experimental integrating or 
removing parts of the DNA sequence (after the muta-
tion fashion), the possibility of dissipative self-organi-
zation of the genome as a structure determining the 
internal state of cells was identified. This, however, 
entails the necessity to understand not only the mor-
phological (material) changes, but also the concurrent 
and equivalent energy transformations, which is the 
subject matter of medical thermodynamics (Klimek 
2001a, 2001c, 2007b, 2010). In 1967, I. Prigogine 
described the common phenomenon called self-orga-
nization of dissipative structures, for which he received 
the Noble Prize 10 years later (Prigogine 1980). Sci-
entifically, it is called the extension of the second 
thermodynamics law and contributes to clearing up 
the mystery of cancer by R. Klimek in 1977 (Klimek 
2001d, 2003, 2004, 2006). Earlier, there was simply no 
chance for associating the carcinogenesis with the self-
organization of dissipative structures. The terminology 
concerning those structures is still difficult to internal-
ize for doctors, despite the fact that it was presented 
in detail as long as 30 years ago in gynaecological 
literature (Klimek 1987a, 1978b, 1980, 1985a, 1981b, 
1989b, 1989c, 1990a, 1990b, 1990c, 1990d; Klimek et al. 
1999b). Unfortunately, they have to supplement their 
education in this field by themselves, as they are more 
and more frequently using spectroscopy and nuclear 
magnetic resonance imaging. Three dimensional 
pictures of the body inside are produced by register-
ing milliards of resonating atoms and particles, con-
currently allowing for their matter and energy states 
(Hollis 1987; Klimek et al. 1981a, 1981b, 1982; Mann 
et al. 1984). However, the thing is that not only does 
it require to understand the technology of medical 
devices, which is presented in manuals anyway, but in 
the first place it has to do with fundamental change in 
the diagnostic-therapeutic proceedings in line with the 
new terminology (Fedor-Freybergh 1988, 1992; Fedor-
Freybergh et al. 1993; Hodorowicz et al. 2011; Jasiczek 
& Klimek 2011; Klimek 2007b; Klimek et al. 2011).
Cells, like all multicellular organism, in order to 
exist, must exchange matter and energy with the sur-
rounding environment through their rims, and these 
processes are dependent on the absolute temperature. 
Like in case of humans who, because of the mere fact 
of growing old, lose strength and wellness in their old 
age, such a useless loss underlying all phenomena is 
defined as entropy and is treated as a measure of disar-
ray (chaos) of every system. The more disarrayed is the 
system, the biggest are the losses. The notion of entropy 
is extremely important in relation to biological systems 
(e.g. organism, cells, cell nucleus or cell cytoplasm) 
because the sum of the entropies of the system and its 
surrounding environment must always be positive. If 
for any reason the cell, in order to maintain its metabo-
lism, reduces the production of its own entropy, it must 
increase it in its surrounding by means of, most gener-
ally understood, dissipation of matter and/or energy. 
The neoplastic cell, which in its surrounding, namely 
in the human organism, as it proliferates in a clone-like 
manner, causes an increasing disorganization which 
leads to its wasting (neoplastic cachexy), is in fact such 
a dissipative system.
Understanding the self-organization of dissipative 
structures as a natural phenomenon, which was first 
described in physics, chemistry and sociology, became 
necessary in the contemporary oncology. However, the 
failure to adequately embrace discoveries in general 
requires a more detailed explanation based on the well 
over a hundred years long history of social reaction to 
successive breakthrough discoveries made by the Jagiel-
lonian University researchers to this regard, ended with 
the description of cervical and ovarian neoplasms as 
dissipative structures (Kaim et al. 2001; Klimek 1985a, 
1990a, 2002; Klimek et al. 2001).
HISTORY OF THE DISCOVERY OF THE 
DISSIPATIVE SELF-ORGANIZATION OF 
CANCER 
Nicolaus Copernicus, during his philosophical and 
astronomical studies at the Cracovian University 
between 1491 and 1495, presented the new heliocen-
tric astronomical concept before he commenced the 
canonical law studies in Italy (1496–1500). During his 
second stay in this country, while doing medical stud-
ies in Padova (1501–1503), in his work ‘On the Helio-
centric Structure of the Universe’, he substantiated his 
view on the daily and yearly motion and the so-called 
declination motion (Markowski 2008). In retrospect, 
after several centuries, his subsequent epoch-making 
work entitled: ‘De revolutionibus libri sex’ can be 
reduced to the simple statement about stopping the 
sun and moving the earth. For the medieval men this 
seemed unbelievable and proved dangerous and even 
life-threatening for men like Giordano Bruno who 
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understood and furthered the Copernican vision of the 
universe. Then, five centuries later, the professors of 
the Jagiellonian University K. Olszewski and Z. Wró-
blewski, as first, liquefied oxygen and nitrogen from air, 
and also solidified carbon dioxide and alcohol, which 
was immediately recognized and commonly acknowl-
edged as a scientific achievement. Simultaneously, L. 
Marchlewski showed similarity between the porphyrin 
structure of haemoglobin and chlorophyll, thus indicat-
ing the metabolic sameness unity in using oxygen by 
animals and plants; it was complemented by R. Klimek, 
B. Skarżyński and T. Szczepkowski, between 1954 and 
1956, (Klimek et al. 1956; Skarżyński et al. 1956) who 
proved its similarity also to haemoproteins (cyto-
chroms) in chemosynthetizing autotrophic bacteria. 
This monumental achievement cannot be compared to 
moving the earth around stopping the sun or liquefying 
of ‘air’, which can be comprehensible to the public, as it 
requires adequate education and/or personal interest. It 
also applies to the discovery, made by the effort of sev-
eral generations of the Jagiellonian University scholars, 
of the natural cause of occurrence of neoplasms and the 
resulting diseases. 
B. Skarżyński, as a physician and biochemist, jointly 
with the Nobel Prize laureate in chemistry from 1929 
– H. von Euler-Cheplin – wrote the most important 
work in his life entitled: ‘Biochemie der Tumoren’ 
(1942, F. Enke Verlag, Stuttgart), translated into Ital-
ian in 1945 (von Euler & Skarzyński 1942)! He ended 
his several dozen year long studies on the pathogen-
esis of neoplasms in 1955 with the following statement: 
‘The essential moment in neoplastic transformation of 
normal tissue is the cell damage that does not go as far 
as to render the cell incapable of living, but transforms 
it sufficiently to specifically transform its metabolism. 
According to the biochemistry facts, cancerogenesis 
would be the reaction of normal tissue to constantly 
repeated insignificant damage and to unfavourable 
environment created by the cancerogenous factor’ 
(Klimek 2006). He was not able to indicate a single 
factor causing neogenesis, however, his generalization 
made it possible for R. Klimek to use his own studies 
on neuroendocrine cervical cancer to describe the etio-
pathogenesis of neoplastic cells as the self-organizing 
dissipative structures (Klimek 2001a, 2007b, 2010). 
What turned out to be the sufficient cause of neo-
plasms, was the internal dissipathogenic state of cells, 
which can result from numerous possible and neces-
sary factors.
The introduction of spectroscopy and nuclear mag-
netic resonance (NMR) imaging to the medicine made 
it possible for R. Klimek, in 1980, together with the 
originator of this method P. Lauterbur (doctor honoris 
causa at the Jagiellonian University, 1988, and Nobel 
Prize laureate, 2003) to verify the thermodynamic 
theory of neogenesis by recognizing and differentiating 
between cancerous and precancerous cells, based on 
cervical and vulval cancers (Klimek et al. 1981a, 1981b, 
1982; Mann et al. 1984). Thus, completely new oppor-
tunities appeared for primary oncological prophylaxis 
by influencing the environment, and not only cell sys-
tems at risk of ending their metabolism in the present 
form of life. Such a line of thermodynamic reasoning 
has an over a hundred year long history at the Jagiello-
nian University, starting with the pioneering works by 
M. Smoluchowski on the role of thermal fluctuation in 
the functioning of life systems, through the studies by 
T. Szczepkowski and J. Hennel on the nuclear magnetic 
resonance of proteins in the middle of the 20. century, 
to the dozen or so year long work of the Inter-Univer-
sity NMR Team managed by R. Klimek, which included 
building an advanced centre for clinical imaging (NMR) 
diagnostics and primary studies on psycho-emotional 
states of the human brain. It fundamentally changes 
the prophylaxis and therapy for neoplastic diseases 
and should definitely beneficially change the results 
of the fight with cervical cancer, provided the essence 
of energy-information transformations, and not only 
material changes in human organism, are understood 
by doctors (Klimek et al. 1983; Szymanski 1999; Klimek 
et al. 2011). For instance, it results from the demo-
graphic data that this cancer is a disease connected 
with low social and economic status, lack of access to 
healthcare, cigarette smoking, alcoholism, sexual con-
tacts at an early age and with many partners, which is 
often associated with infectious sexually transmitted 
diseases, pregnancies at a too early age, pathological 
course of pregnancies and deliveries, especially of the 
premature ones, as well as lack of or shortened lactation 
(Cosmi et al. 1997; Klimek 1996; Klimek 1989a, 1992a, 
1992b, 1992c, 1997, 1998a, 1998b, 1999, 2001a, 2001b, 
2001c, 2001d, 2002). It is associated with erroneous 
diagnostic and therapeutic proceedings (Klimek et al. 
1999a, Klimek et al. 1999b, 1996; 2006, 2000; Tomasze-
wska et al. 2000), and recently also frightening with 
cancer as the fatal illness in media advertisements of 
vaccines against one virus (Majewski & Sikorski 2006; 
Pisarski 2007). Meanwhile, the similarity between fac-
tors for this cancer and for infectious diseases, and even 
their sameness with the factors for premature deliver-
ies (Klimek 1996; Klimek et al. 2002; Klimek & Klimek 
1990), should make the primary prophylaxis against 
this disease easier, and not reduce it to the preven-
tion of infections with only several out of nearly 200 
types of one virus, with harmful and thus unacceptable 
omission of the above mentioned risk factors, and not 
only many other pathogenic microorganisms (Klimek 
1990d, 2001b; Klimek & Paradysz 1969; Malarewicz 
1994, 2007).
Cervical cancer can be not only prevented, but also 
effectively treated in spite of increased incidence in 
women due to the growing number of operative deliv-
eries and inadequate use of steroid preparations as con-
traceptive tablets or menopausal therapies. Recently, a 
multiple increase of risk for this disease was showed in 
connection with the use of contraceptive tablets (Smith 
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et al. 2003; Vessey & Painter 2006; Zondervan et al. 
1996) and, obviously, the risk additionally grows when 
associated with the infection with human papilloma-
virus (Cogliano et al. 2005; Moreno et al. 2002). One 
cannot omit the fact that it is the very virus that – as 
its name indicates – infects humans who, when healthy, 
have been effectively eliminating it for centuries. Only 
decreased efficiency of biochemical, neurohormonal 
and/or immunological mechanisms leads to infectious 
states which, irrespective of their bacterial, viral or par-
asitic aetiology, are only the necessary, but not the suf-
ficient, causes of neogenesis. It is not the virus, but only 
the infection caused by the virus that becomes an onco-
genic factor, as the germ itself is a sufficient cause of for-
mation of papilla, which indicates the infectious disease. 
INFECTION AND PRECANCEROUS STATE 
Infected cells or infectiously changed tissues in their 
final phase of existence are often recognized as a pre-
cancerous state, but their genome does not differ from 
other organism cells, and that is why the carcinogenesis 
can still be prevented by direct fighting of pathogenic 
microorganisms, and indirectly by strengthening the 
body by neurohormonal therapy or vaccine immuno-
potentialization. However, the anti-viral or anti-bacteria 
vaccines cannot be called anti-cancer, as every neoplasm 
has a unique identity, irrespective of the type and the 
factors, which are always numerous, that lead to ending 
of the cells existence. However, some natural agents, e.g. 
saprophytic bacteria of the Lactobacillus vaginalis type, 
which maintain proper pH of the vagina and cooperate 
with the organism also in the direct fighting of infec-
tious microorganisms, whose antigens they recognize, 
should be used, especially in precancerous states. This 
is how in Poland, 20 years ago, the introduction of the 
vaccine comprising coccoidal and weakened forms 
of Lactobacillus vaginalis (SolcoTrichovac-Gynatren) 
began – it was meant for fighting precancerous states 
of cervix in women treated for infertility, in whom 
intraepithelial neoplasia and/or non-specific vaginitis 
was found (Bałajewicz et al. 1989; Klimek 1986, 1987, 
1988a, 1988b, 2007a; Klimek et al. 1986; Klimek & 
Madej 1985; Madej & Klimek 1988). The efficiency of 
such an immunopotentialization is showed by quick 
normalization of the clinical state of cervix found after 
administration of only two vaccine doses, at two-week 
intervals, which in 0.5 ml includes 7×109 of bacteria. For 
instance, 38 women aged 28 ± 4.2 years (the 20–35 years 
range) with cytologically and/or colposcopically diag-
nosed intraepithelial neoplasia (group 1) were observed 
and compared with concurrently treated (also due to 
infertility) 41 female patients aged 29.5 ± 3.5 years (the 
20–36 range) diagnosed with bacterial vaginosis (group 
2). In neither group the clinical or cytological signs of 
viral infection of the reproductive organ were found. 
During the 4-week immunopotentialization, the statis-
tically significant (p<0.001) normalization of the cervix 
state was found in 27 women (68.2%), which, at subse-
quent 2-week intervals, has been presented in Table 1 
in relation to the cytological results (chi2 = 26.2), and 
in Table 2 – in relation to the colposcopic assessment 
(chi2 = 20).
In Table 3, the starting and ending cytological 
evaluations of vaginal smears (inflammatory changes, 
presence of Lactobacillus vaginalis, presence of meta-
plastic cells) and the results of the colposcopic evalu-
ation (inflammatory state, regeneration zone, vessel 
presence) in group 1 in relation to group 2, excluding 
precancerous states, have been presented.
It results from the tables that vaccination, even after 
two doses, leads to the significant reduction in the 
inflammatory state rates and the size of the vascular 
bed, and concurrently increases the regeneration zones 
and the number of saprophytic Lactobacillus vaginalis 
bacteria. What is noticeable, is the lack of distinct dif-
ferences in the rates of metaplastic cells, and increased 
effect of immunopotentialization on non-oncologi-
cal indexes in women with intraepithelial neoplasia 
Tab. 1. Effect of two injections of Gynatren on cytological diagnosis of 
CIN.
Week 0 2 4
CIN- 5 14 27
I 21 12 7
II 10 5 3
III 2 1 1
Tab. 2. Effect of two injections of Gynatren on colposcopic 
diagnosis of the precancerous states of cervix.
Week 0 2 4
Changes - 6 7 27
+ 26 12 10
++ 6 2 1
Tab. 3. Cytological and colposcopic starting and ending results (%) of 
two injections of Gynatren with respect to CIN presence.
Week 0 4
CIN Yes No Yes No
Cytology
Inflammation 63% 63% 27% 17%
Lactobacillus vag. 54% 66% 76% 88%
Metaplasia 97% 98% 97% 80%
Colposcopy
Inflammation 81% 90% 44% 70%
Regeneration 5% 40% 32% 52%
Vessels 46% 40% 18% 13%
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(group 1) compared with women without it (group 2) 
with identical 22% increase in the number of Lactoba-
cillus vaginalis.
The SolcoTrichovac-Gynatren vaccine, comprising 
coccoidal and weakened forms of selected strains of 
Döderlein acts directly on pathogens of the non-spe-
cific inflammation and trichomoniasis. Even after the 
first injection, after 2–3 weeks antibodies against anti-
gens of the majority of pathological microorganisms 
are produced and simultaneously the Döderlein bacilli 
are quickly renewed; and after three injections made 
at 2-week intervals they ensure a one-year period of 
immunological protection against infections (Bonilla-
Musoles et al. 1983; Milovanowic et al. 1980; Ruttgers 
1984). The use of the vaccine, as presented in Tables 
1–3, rapidly changes the environment of the vagina and 
thus normalizes the surrounding of the precancerous 
cells, making the neoplastic transformation difficult or 
even impossible (Buchner et al. 1988; Klimek 1988a, 
1998b; Klimek et al. 1989; Klimek & Madej 1985). That 
is the fundamental difference between this immuno-
prophylaxis and the treatment for precancerous states 
on the one hand, and the effect of the vaccine against 
several types of one of a hundred and a few dozen types 
of the HPV virus on the other hand. This virus is only 
one of the numerous factors and not the only cause of 
pathological cell structures. Also, the role of virusology 
as an independent scientific discipline should not be 
discounted; according to it, successful fighting of any 
virus cannot take place without common vaccination, 
especially with the use of the Silgard (Gardasil) vaccine 
which, according to the characteristics prepared by the 
manufacturer, is ineffective in the event that HPV has 
been found at the first injection. The more so, during 
the anticipated collection of evidence for possible effec-
tiveness of Silgard in the next 15–20 years, the pro-
spective clients should not be frightened with the fatal 
disease, whose risk increases by several times after, for 
example, only several years of using contraceptive tab-
lets by persons not infected with HPV (Moreno et al. 
2002).
Iatrogenic and social factors predisposing to cervical 
cancer, also called a ‘mothers’ cancer and/or ‘cancer of 
sexual activity at an early age’ – are well documented 
and cannot be replaced by any, especially prema-
turely advertised, vaccines presented as first and only 
one, in defiance of international literature and Polish 
experience with the SolcoTrichovac-Gynatren vaccine 
(Klimek & Klimek 1990; Klimek 1992b, 1992c, 1997, 
1998a; Klimek et al. 2006). Due to the naturalness of 
procreation, what is particularly evident is the lack of 
sufficient primary prophylaxis of all diseases, and not 
only infectious or neoplastic ones, in women, which 
results from 10 main manifestations of gynaecologists’ 
negligence:
1. Causing the increase in the number of operative 
deliveries and prematurity due to lack of under-
standing of the relativity of pregnancy duration: 
281 ± 11 days, the range of 259–302 days;
2. Discounting the incidence of hypothalamic post-
partum and juvenile syndromes as the causes of 
the pathological course of pregnancies, premature 
deliveries, lactation disorders and increased onco-
logical risk (in about 20% of those female patients 
intraepithelial neoplasia of cervix is found).
3. Only one-sided oncological evaluation of the vaginal 
smear cytology, without providing available infor-
mation on the neurohormonal and inflammatory 
states of the vagina.
4. Failure to conduct the enzymatic monitoring of 
pregnancies by measuring the concentration of 
oxytocinase (CAP1) and isooxytocinase (CAP2) as 
the most stable enzymes regulating the activity of 
neurohormones and indirectly the whole steroido-
genesis in the organism.
5. Use of dexamethasone and betametasone instead of 
natural sustained-action adrenocorticotropine for 
preventing miscarriages and premature deliveries in 
mothers and prematurity in neonates.
6. Failure to evaluate, directly after the delivery, the 
degree of neonate maturity concurrently with the 
quickness of his/her respiratory adaptation with 
respect to the Apgar score for the retrospective eval-
uation of obstetrical proceedings.
7. Failure to understand the necessity to concurrently 
evaluate the matter and energy states in the face of 
increasingly common clinical imaging and spectros-
copy with the use of nuclear magnetic resonance.
8. Increasing the oncological risk due to failure to 
understand the thermodynamic etiopathogenesis of 
neoplasms and the resulting neoplastic diseases.
9. Failure to concurrently treat infertility in both sexual 
partners who in other relationships can be healthy 
(fertile).
10. Uncritical adoption of free, pseudoscientific infor-
mation, and at the same time discounting Polish 
theoretical and practical achievements, even by 
authors of medical textbooks and gynaecological-
obstetrical recommendations .
PROPHYLAXIS AND TREATMENT
Primary prophylaxis of neoplasms requires that not 
only the dissipathogenic state of cells be prevented, 
but also their tissue surrounding be normalized to 
head off the risk of the self-organization of neoplastic 
forms of life, differing in their genetic identity from 
the surrounding cells. Pathological states of cells can 
recede after neurohormonal normalization and/or 
immunopotentialization of their surrounding, which 
in the event that the operative resection of neoplasms 
is necessary, especially in early phases of the disease, 
significantly improves the results of oncological treat-
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ment (Klimek 1985b, 1990a, 1990b, 1990c). Many pos-
sible and even necessary factors and conditions can lead 
the cell metabolism to the end of its existence, which is 
clinically defined as the precancerous state of cells. For 
instance, cervical cancer is the best investigated neo-
plasm in women, whose possible and necessary factors 
can be placed in a huge range from genetic inherited 
states to psycho-emotional behaviour of humans in the 
constantly changing socio-economical environment. 
It should be noted that the same factors remain in a 
cause-and-effect relationship with the occurrence of 
premature deliveries (Jasiczek & Klimek 2011; Klimek 
et al. 2002). About 20% of women with post-partum 
neurohormonal disorders have clinically recognizable 
precancerous states of cervix due to, among others, 
obstetrical haemorrhages, miscarriages and premature 
deliveries (Klimek 1978b; Klimek & Paradysz 1969). 
Also, the pathogenic human papilloma virus (HPV) is 
only a potential, but not necessary factor for cervical 
cancer, as the cancer can be diagnosed in the absence of 
the virus. In Poland, in 2006, HPV was the cause of con-
dylomata acuminata in 3 female patients out of 100 000, 
whereas in the same population, 41 female patients died 
because of cervical cancer (Niemiec 2007). At the same 
time, the very use of contraceptive tablets increases the 
risk of this type of cancer in women several times, irre-
spective of the infectious diseases (Klimek et al. 2011).
Neither HPV viruses, nor contraceptive tablets, nor 
many other bacteria or viruses, can be classified as fac-
tors sufficient for the neogenesis. Their complete elimi-
nation, even as necessary factors, can only reduce the 
incidence, as it is the factors reducing reparative and 
defensive mechanisms of the whole organism, e.g. nar-
cotics, stimulants or even low socio-economical status 
or inadequate nutrition, and even the fact of threaten-
ing with cancer or using the very term in advertising, 
that have a much stronger pathological effect. In the 
first place, the treatment of even least advanced pre-
cancerous states, e.g. intraepithelial cervical neoplasia 
(CIN1), cannot be given up only because of the fact that 
in 50% it diminishes, as in the other half of the affected 
women the neoplastic disease develops.
Neoplasm, like every new dissipative system, does 
not have its own history because it develops de novo as 
one of many possible biological structures in equally 
unique biological surrounding whose condition deter-
mines the development of the neoplastic disease. There 
are no two identical neoplasms, even when developed 
separately in the same organ in the human body. The 
fact of unique genetic identity of every neoplasm must 
be taken into consideration when defining any vaccine 
as directed against cancer, especially when understood 
as a neoplastic disease, e.g. cervical cancer. Calling the 
commonly used vaccine the influenza-preventing vac-
cine can be justified only in this sense that without 
the presence of any type of influenza virus the disease 
cannot develop as the sufficient and only cause of this 
disease is the virus of influenza itself, which unfortu-
nately constantly mutates. Meanwhile, there is no virus 
of cancer whose only possible or even necessary causes 
would be germs. After all, there are many other and 
more frequent types of such factors apart from infec-
tions; in relation to cervical cancer even up to 120 
(Klimek 2001d; Klimek et al. 2011; Klimek & Walas-
Skolicka 1977). Informing women about vaccinations 
against cervical cancer and not – as is the case – only 
against several types of human papilloma virus in 
advertising is unacceptable.
Neoplastic diseases are not contagious and there-
fore one cannot become infected with them like with 
influenza, which can take place even in spite of earlier 
vaccination against several types of influenza-causing 
viruses, if other types or rather new mutations are caus-
ing individual incidence. In contrast to neoplastic dis-
eases, in infectious diseases the causes of the disease can 
be isolated from the patient organism, e.g. viruses or 
bacteria, and used to infect other persons. However, in 
spite of many attempts, implantation of cancerous cells 
into healthy humans does not cause them to develop 
a neoplastic disease. Experimentally, one can integrate 
viruses into the animal cell genome, however, even 
the subsequent, isolated from it and corresponding to 
the integrated virus sequences of nucleotides, are not 
infectious (Hodorowicz et al. 2011; Klimek et al. 2011; 
Klimek et al. 2006).
From the point of view of medical thermodynam-
ics, what is the sufficient cause of any neoplastic dis-
ease is not a material factor, but a natural phenomenon 
of the self-organization of dissipative systems. By way 
of destroying germs or preventing infections, many 
infectious diseases can be causally reduced or elimi-
nated; however, in order to fight neoplasms as a natu-
ral phenomenon, a completely new strategy needs to 
be applied, similar to building lightning rods or early 
warning stations for pernicious forces of nature. It 
means the necessity to medically improve reparative-
defensive mechanisms of the whole organism. And the 
methods and means applied for that purpose must be 
Tab. 4. Characteristics of the vaccines Gynatren and Gardasil.
The vaccine Gynatren (Lyseen) Gardasil(Silgard)
Action Prophylaxis and treatment Prophylaxis




specific infections and 
inflammations of female 
reproductive organs




states of cervix 
(CIN1-3)
Effective No indications
Effects Cytological and colposcopic even during the vaccination
Possibly in 20 
years
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used, and especially advertised, in accordance with the 
current state of knowledge, as presented in Table  4, 
which juxtaposes the characteristics of the vaccines: 
Gynateren (Lyseen) and Gardasil (Silgard).
Gardasil acts prophylactically on the protein compo-
nent of only 4 selected types of HPV. Gynatren, on the 
other hand, contains antigens characteristic of patho-
logical flora of the vagina and in addition promotes the 
presence of saprophytic bacteria of lactic acid. Such a 
lactovaginal immunopotentialization complements 
the conservative and operative methods of oncologi-
cal treatment, as well as has prophylactic application 
in women with the history of miscarriages, premature 
deliveries, lack of or significantly shortened lactation, 
neurohormonal menstruating disorders, chronic and 
recurrent inflammations of the reproductive organs, 
long-term hormonal contraception and hormone 
replacement therapy during menopause, or only defi-
ciency of Lactobacillus vaginalis, as indicators of risk of 
cervical cancer. 
CONCLUSIONS 
The most effective prophylaxis of neoplasms is ade-
quate upbringing and educating every human being to 
live and work in line with the auto-teleological prin-
ciples of the concordance between actions and recog-
nized ethical values. Teleology recognizes the existence 
of purpose components even in the very cause of every 
event. For example, viruses infect the cervical intraepi-
thelial cells for the purpose of their own survival and 
numerical multiplication, and not for the purpose 
of neoplastic transformations, which is destructive 
even for the viruses themselves, as well as for germs. 
Viruses make use of the natural phenomenon of shed-
ding of epithelial cells, by which, already multiplied, 
they spread in the human environment. Uniquely, 
the infected cell does not have to vanish or undergo 
shedding if it makes use of the vitality (life) of virus 
and enters endosymbiosis with it, that is integrates it 
into its genome. By way of such a self-organization, 
which is possible only by increasing the dissipation of 
matter and energy in the nearest biological surround-
ing – the genetic identity of the previous form of life 
of such a cell undergoes a change, and simultaneously 
the multiplication of viruses is discontinued. Thus the 
causal purpose of the viral infection itself disappears! 
Instead, the cloning of cervical cancer cells, which are 
responsible for the development of ailments and symp-
toms of the disease called cervical caner, begin. This, 
in turn, eliminates persons whose defensive-reparative 
mechanisms did not fight the viral infection from 
the human population. Thus, in the general biologi-
cal sense, the cancer turns out to be the regulator of 
the size of the Homo sapiens population and at the 
same time the barrier for the reproduction of human 
viruses. The recovery or spontaneous resolution of 
the infection with human papillomavirus, which takes 
place in several dozen percent, does not ensure per-
manent resistance to this disease, let alone to the neo-
plasms as self-organizing, unique biological dissipative 
structures.
The cause of cancer is the natural and common phe-
nomenon of the self-organization of systems, endan-
gered by ending of their existence, into more efficient 
time-space structures at the expense of their surround-
ing. With respect to humans, it means that cancero-
genesis cannot be eliminated, but the development and 
progress of diseases caused by neoplastic cells can and 
should be effectively prevented; and in fact, the diseases 
are increasingly often curable.
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